Research teams, sponsors and CROs comparing data collection for clinical trials, from focused participant-centered studies to complex multi-site protocols.
Scope Dedicated EDC systems and participant-centered clinical-trial data collection are compared by their documented capabilities. Whether a participant-centered platform also needs a dedicated EDC depends on in-visit data entry, clinical queries, coding, verification and database-management requirements, rather than study size or trial phase alone.
These notes describe the products in the EDC guide.
REDCap
Best for
Academic and non-profit teams running investigator-initiated studies, as a free baseline.
What to consider
REDCap is the free academic baseline, with open data standards and very wide adoption. It comes without vendor support, its Part 11 status depends on each institution, and sponsors and CROs cannot license it.
Sponsors and CROs already on Veeva's clinical platform who want EDC, RTSM, eCOA and CTMS from the same vendor.
What to consider
Veeva EDC documents mid-study changes and connected clinical applications, and Veeva says eight of the top 20 biopharmas have switched to it. Veeva publishes no study count and no prices.
Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.
Expand a feature definition or support note for context and its original source.
REDCap vs Veeva EDC (EDC): category feature evidence and sources. Products are not ranked.
Category feature
REDCap
Veeva EDC
Track record in regulated multi-site trialsFeature definitions
Supported
Published product or wider-platform adoption, or a named clinical-research deployment.
Extended support
Product-specific study, customer, institution, site or participant figures plus a published country count establish international use.
REDCap
Extended support
The REDCap Consortium lists 8,526 institutions in 167 countries and 2.9M projects, but REDCap is licensed to non-profits and its use is concentrated in academic research.
Self-build and approval of production changes are stated; uninterrupted changes are not established.
Veeva EDC
Supported
Veeva's white paper states that amendments add new elements without bringing the system down or migrating data, with only a brief casebook lockout while a change deploys.
Amendments avoid system shutdown, but deployment includes a brief casebook lockout.
Compliance and securityFeature definitions
Supported
Relevant trial compliance or security controls are stated, with their scope identified.
Extended support
Relevant trial controls and a publicly accessible ISO certificate or SOC audit report covering the product or vendor are documented.
REDCap
Supported
Vanderbilt says REDCap can be installed for 21 CFR Part 11 compliance, but this depends on each institution's setup; Penn Medicine, for example, states its REDCap is not Part 11-compliant.
Part 11 support depends on institutional setup; the note also identifies a non-compliant host.
Veeva EDC
Supported
Veeva's trust page lists ISO 27001, ISO 27017, ISO 27018 and a SOC 2 Type II report, and its EDC help docs state that Veeva EDC eSignature meets 21 CFR Part 11.
Veeva documents a versioned CDMS API for study data, definitions and coding requests with a data model similar to CDISC ODM, but its ODM casebook export is a legacy feature.